Cash & equivalents increased 112.6%
Cash & equivalents changed +112.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +112.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Gross margin changed +570 basis points from the comparable as-filed period.
Gross profit changed +28.8% from the comparable as-filed period.
Inventory changed -13.6% from the comparable as-filed period. The change ranks at the 100th percentile of 4 prior comparable changes.
Net income changed +102.2% from the comparable as-filed period.
Operating income changed +106.1% from the comparable as-filed period.
Operating margin changed +16157 basis points from the comparable as-filed period.
Research & development changed +15.4% from the comparable as-filed period.
Stock-based compensation changed +100.0% from the comparable as-filed period.
Revenue changed +7.3% from the comparable as-filed period.
Selling, general & administrative changed -6.6% from the comparable as-filed period.
Debt changed -0.6% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.